Kim Chang-Gon, Mun Su-Jeong, Kim Ka-Na, Shin Byung-Cheul, Kim Nam-Kwen, Lee Dong-Hyo, Lee Jung-Han
Department of Rehabilitation Medicine, College of Korean Medicine, Won-Kwang University, Iksan, Korea.
Mibyeong Research Center, Korea Institute of Oriental Medicine, Daejeon, Korea.
BMJ Open. 2016 May 13;6(5):e010556. doi: 10.1136/bmjopen-2015-010556.
Manual therapy is the non-surgical conservative management of musculoskeletal disorders using the practitioner's hands on the patient's body for diagnosing and treating disease. The aim of this study is to systematically review trial-based economic evaluations of manual therapy relative to other interventions used for the management of musculoskeletal diseases.
Randomised clinical trials (RCTs) on the economic evaluation of manual therapy for musculoskeletal diseases will be included in the review. The following databases will be searched from their inception: Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Econlit, Mantis, Index to Chiropractic Literature, Science Citation Index, Social Science Citation Index, Allied and Complementary Medicine Database (AMED), Cochrane Database of Systematic Reviews (CDSR), National Health Service Database of Abstracts of Reviews of Effects (NHS DARE), National Health Service Health Technology Assessment Database (NHS HTA), National Health Service Economic Evaluation Database (NHS EED), CENTRAL, five Korean medical databases (Oriental Medicine Advanced Searching Integrated System (OASIS), Research Information Service System (RISS), DBPIA, Korean Traditional Knowledge Portal (KTKP) and KoreaMed) and three Chinese databases (China National Knowledge Infrastructure (CNKI), VIP and Wanfang). The evidence for the cost-effectiveness, cost-utility and cost-benefit of manual therapy for musculoskeletal diseases will be assessed as the primary outcome. Health-related quality of life and adverse effects will be assessed as secondary outcomes. We will critically appraise the included studies using the Cochrane risk of bias tool and the Drummond checklist. Results will be summarised using Slavin's qualitative best-evidence synthesis approach.
The results of the study will be disseminated via a peer-reviewed journal and/or conference presentations.
PROSPERO CRD42015026757.
手法治疗是通过从业者用手作用于患者身体来对肌肉骨骼疾病进行非手术保守治疗，以诊断和治疗疾病。本研究的目的是系统评价基于试验的手法治疗与用于肌肉骨骼疾病管理的其他干预措施相比的经济学评价。
本综述将纳入关于手法治疗肌肉骨骼疾病的经济学评价的随机临床试验（RCT）。将从数据库创建之初开始检索以下数据库：医学文献数据库（Medline）、荷兰医学文摘数据库（Embase）、Cochrane对照试验中心注册库（CENTRAL）、护理学与健康相关文献累积索引（CINAHL）、经济学文献数据库（Econlit）、Mantis、脊椎按摩疗法文献索引、科学引文索引、社会科学引文索引、补充与替代医学数据库（AMED）、Cochrane系统评价数据库（CDSR）、英国国家卫生服务系统疗效综述摘要数据库（NHS DARE）、英国国家卫生服务系统卫生技术评估数据库（NHS HTA）、英国国家卫生服务系统经济评价数据库（NHS EED）、CENTRAL、五个韩国医学数据库（韩医高级检索集成系统（OASIS）、研究信息服务系统（RISS）、DBPIA、韩国传统知识门户（KTKP）和韩国医学数据库（KoreaMed））以及三个中国数据库（中国知网（CNKI）、维普和万方）。手法治疗肌肉骨骼疾病的成本效益、成本效用和成本效益证据将作为主要结局进行评估。与健康相关的生活质量和不良反应将作为次要结局进行评估。我们将使用Cochrane偏倚风险工具和德拉蒙德清单对纳入研究进行严格评价。结果将使用斯拉文定性最佳证据综合方法进行总结。
本研究结果将通过同行评审期刊和/或会议报告进行传播。
PROSPERO CRD42015026757。
